ACS Nano · 2022 · 66 citations · 34 references
MedicineImmunologyOncologyCancer ImmunologyImmunotherapyTumor MicroenvironmentCancer ImmunotherapyCheckpoint Inhibitor TherapyCombination ImmunotherapyImmune Checkpoint InhibitorsTumor Immune MicroenvironmentTumor-associated MacrophagesCancer-associated MacrophagesCytotoxic T Lymphocyte InfiltrationImmune Checkpoint Inhibitor TherapyImmunosuppressive MicroenvironmentLipid NanoparticlesProgrammed Cell Death Ligand 1 SignalingTumor Microenvironment EffectsTumor-associated Macrophage Polarization
While checkpoint blockade immunotherapy as a promising clinical modality has revolutionized cancer treatment, it is of benefit to only a subset of patients because of the tumor immunosuppressive microenvironment. Herein, we report that the specified delivery of vitamin C at the tumor site by responsive lipid nanoparticles can efficiently induce oxidative toxicity and the polarization of M1 macrophages, promoting the infiltration of activating cytotoxic T lymphocytes in the tumor microenvironment for intensive immune checkpoint blocking therapy. Both in vitro and in vivo assays demonstrate successful vitamin C-induced polarization of M2 macrophages to M1 macrophages. In vivo transcriptome analysis also reveals the activation mechanism of vitamin C immunity. More importantly, the combination approach displays much better immune response and immune process within the tumor microenvironment than clinical programmed cell death ligand 1 (Anti-PD-L1) alone. This work provides a powerful therapeutic application of vitamin C to amplify Anti-PD-L1 immunotherapy in cancer treatment, which brings hope to patients with clinically insensitive immunity.
34
Qi Chen, Michael Graham Espey, Murali C. Krishna et al. · Proceedings of the National Academy of Sciences · 2005 · 1.1K citations · Full text
Medicine, Oncology, Pharmacology +15
Vitamin C Pharmacokinetics: Implications for Oral and Intravenous Use
Sebastian J. Padayatty, He Sun, Yaohui Wang et al. · Annals of Internal Medicine · 2004 · 967 citations
Jihye Yun, Edouard Mullarky, Changyuan Lu et al. · Science · 2015 · 910 citations
Medicine, Cancer Biology, Oncology +14